| Dr Steven J Humphrey, MD | |
|
14961 Woodcreek Ln, Clive, IA 50325-4511 | |
| (515) 865-4501 | |
| Not Available |
| Full Name | Dr Steven J Humphrey |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 14961 Woodcreek Ln, Clive, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447656046 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 21106 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven J Humphrey, MD 14961 Woodcreek Ln, Clive, IA 50325-4511 Ph: (515) 865-4501 | Dr Steven J Humphrey, MD 14961 Woodcreek Ln, Clive, IA 50325-4511 Ph: (515) 865-4501 |
News Archive
FIJI® Water, the country's leading premium imported bottled water, announced today that it has acquired the award-winning JUSTIN Vineyards & Winery in Paso Robles, California. Known for its Bordeaux-style blends and single varietals, combining Old World tradition with New World techniques, JUSTIN Vineyards & Winery is a critically-acclaimed, world class premium wine brand that FIJI Water and its parent company, Roll International, are proud to add to their portfolio.
Researchers from UPM have taken the first steps towards the development of a sensor for the detection of bacterial meningitis in real time by combining gravimetric sensors with synthetic antibodies giving, as a result, a sensitive, rapid and affordable method.
A revolutionary clinical study has demonstrated the effectiveness of a new drug, vismodegib, in dramatically shrinking and preventing the formation of basal cell skin cancers - the most common cancer in the United States - in patients with basal cell nevus syndrome (BCNS), a rare genetic condition that causes hundreds to thousands of skin cancers primarily treated by surgical removal.
Acura Pharmaceuticals, Inc. today announced that it has been informed by King Pharmaceuticals Research and Development Inc. (King) that King's New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets was accepted for filing by the US Food and Drug Administration (FDA) with a Priority review classification and a Prescription Drug User Fee Act (PDUFA) date of June 17, 2011.
› Verified 7 days ago
Stephen Eckstat, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1601 Nw 114th St, Clive, IA 50325 Phone: 515-222-7000 Fax: 515-222-7037 | |
Dr. Daniel Charles Miller, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12871 University Ave, Suite 130, Clive, IA 50325 Phone: 515-222-4419 Fax: 515-222-6965 | |
Randall Miller, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1601 Nw 114th St, Clive, IA 50325 Phone: 515-222-7000 Fax: 515-222-2737 | |
Lon Russell Brewer, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1924 Nw 88th Ct, Clive, IA 50325 Phone: 515-237-3974 Fax: 515-883-2692 | |
Erin Netteland-sandvig, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Nw 114th St, Clive, IA 50325 Phone: 515-222-7000 Fax: 515-222-7037 | |
Robert D Conner, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13435 University Ave, Suite 500, Clive, IA 50325 Phone: 515-255-7132 Fax: 515-218-1500 |